HK_DOX_WCE_1
Homo sapiens
source_name
Human primary keratinocytes
cell type
Human primary keratinocytes engineered with stable IRF2 shRNA knockdown and a doxycyline inducible IRF2-3xHA allele
input
N/A
treatment
Cells were treated with 1μg/ml Doxycycline for 3 days plus 2 days with 2μg/ml Doxycycline
barcode
GTGTGGTG
antibody
N/A
antibody maker
N/A
antibody catalog number
N/A